Comment by morcus

> But "fair source" cure is a new, unproven drug with serious side effects, all while ignoring the established, effective vaccine (strong copyleft GPL/AGPL and dual-licensing)

Can you explain this a bit more? I don't understand how this is true.

AFAIK AGPL only prevents someone from modifying your AGPL codebase without sharing that in turn, but if they're content to offer exactly the service you're offering without modification it's not an issue.

See for example Grafana, which is distributed under the AGPL but still has to handle competition from AWS and Azure that have managed Grafana offerings.